Cboe CA - Delayed Quote CAD
Eli Lilly and Company (LLY.NE)
31.75
+1.12
+(3.66%)
At close: April 24 at 3:59:32 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
8,817,900
8,817,900
4,240,100
7,585,700
7,365,900
Investing Cash Flow
-9,301,500
-9,301,500
-7,152,700
-3,762,900
-2,867,500
Financing Cash Flow
1,230,100
1,230,100
3,495,600
-5,406,700
-4,131,300
End Cash Position
3,268,400
3,268,400
2,818,600
2,067,000
3,818,500
Capital Expenditure
-8,403,600
-8,403,600
-7,392,100
-2,985,300
-1,978,400
Issuance of Debt
11,417,100
11,417,100
3,958,500
--
2,410,800
Repayment of Debt
-664,200
-664,200
--
-1,560,000
-1,905,400
Repurchase of Capital Stock
-2,500,000
-2,500,000
-750,000
-1,500,000
-1,250,000
Free Cash Flow
414,300
414,300
-3,152,000
4,600,400
5,387,500
12/31/2021 - 9/19/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PFE.NE Pfizer Inc.
10.50
+2.24%
ABBV.NE AbbVie Inc.
25.92
+1.97%
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
20.44
-0.20%
NVON.NE NOVO NORDISK CDR (CAD HEDGED)
6.73
+2.75%
NVS.NE NOVARTIS CDR (CAD HEDGED)
21.68
+1.17%
OTSKF Otsuka Holdings Co., Ltd.
47.80
0.00%
ROG.NE Roche Holding AG
20.82
+2.36%
BAYN.MU Bayer AG
22.40
+1.77%
MRK.NE Merck & Co., Inc.
18.28
+0.88%
NOVA.SG Novo Nordisk A/S
55.10
+0.92%